Evidence map›Paper›PMID 41114660›Full record

Trial reportPain2026

Unraveling nocebo effects in visceral pain: negative suggestion and adverse treatment experience uniquely shape visceral pain unpleasantness.

Jana Luisa Aulenkamp, Robert Jan Pawlik, Catrin Guddat, Harald Engler, Julian Kleine-Borgmann, Adriane Icenhour, Sigrid Elsenbruch

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jana Luisa AulenkampDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Robert Jan PawlikDepartment of Neurology, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Catrin GuddatDepartment of Neurology, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Harald EnglerInstitute of Medical Psychology and Behavioral Immunobiology, Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Julian Kleine-BorgmannDepartment of Neurology, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Adriane IcenhourDepartment of Medical Psychology and Medical Sociology, Center for Medical Psychology and Translational Neuroscience, Ruhr University Bochum, Bochum, Germany.
Sigrid ElsenbruchDepartment of Neurology, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.ORCID 0000-0002-6528-2665

Funding

Deutsche Forschungsgemeinschaft 422744262
6 · The paper itself

Abstract

abstractVisceral pain, characterized by its diffuse, poorly localized, and fear-inducing nature, may be especially prone to nocebo effects. This preregistered experimental study investigated whether (1) visceral pain is more susceptible to nocebo effects than somatic pain, and whether (2) an adverse treatment experience in the somatic modality contributes to visceral nocebo effects by cross-modal generalization. A total of 101 healthy volunteers received inert treatment and were randomized into 4 experimental groups: negative treatment suggestions, adverse somatic treatment experience, their combination, or control. Individually calibrated visceral (rectal distension) and somatic (thermal) pain stimuli were applied. Negative suggestions involved heightened pain sensitivity suggestions; adverse treatment experience was modeled by covertly amplifying thermal pain. Pain ratings, cortisol levels, and emotional states were assessed across pre-, treat-, and test-phases, and upon re-exposure to pain 1 week later. Negative suggestions increased negative expectations and cortisol levels, and the thermal pain manipulation successfully amplified somatic pain during treatment ( P < 0.001). In the test-phase, both suggestions and somatic experience independently increased visceral pain unpleasantness ( P = 0.004; P = 0.011), whereas no somatic nocebo effects emerged. No group differences appeared at re-exposure, but perceived treatment allocation was influenced both by suggestions and experience. Findings support the distinct vulnerability of the visceral modality to nocebo effects, which can arise or intensify through cross-modal transfer from adverse somatic treatment experiences, emphasizing the importance of provider communication and consideration of prior experiences in the treatment of chronic visceral pain conditions, especially in patients with mixed pain phenotypes.

Indexed as

Nocebo EffectSuggestionVisceral PainAdultFemaleHumansHydrocortisoneMalePain MeasurementPain ThresholdYoung AdultHydrocortisoneCortisolGut-brain axisNoceboPain modalityPlaceboStressTreatment expectationVisceral pain

Identifiers

PMID41114660
PMCPMC12890189

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.